#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3774	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2474	452.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1893	1893	T	571	T,C	497,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3774	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2474	452.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1627	1627	C	508	C,A	429,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5966	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3947	452.2	0	.	n	.	0	A9G	SNP	9	9	A	481	481	G	585	G	489	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5966	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3947	452.2	0	.	n	.	0	T695C	SNP	695	695	T	1167	1167	C	415	C,A	328,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5966	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3947	452.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2443	2443	C	593	C,T	500,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5966	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3947	452.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3069	3069	T	489	T,C	403,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5966	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3947	452.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2517	2517	A	620	A,C	519,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	522	folP	855	855	99.77	folP.l15.c4.ctg.1	1807	85.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1197	1199	AGC	117;117;117	A;G;C	97;98;100	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1176	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3695	95.1	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1236	1238	ATA	85;85;85	A;T,C;A	69;71,2;70	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1176	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3695	95.1	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1257	1259	ATA	86;85;84	A;T;A,G	72;68;70,2	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1176	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3695	95.1	1	SNP	p	S91F	0	.	.	271	273	TCC	780	782	TCC	98;98;98	T;C,T;C	81;81,2;80	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1176	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3695	95.1	1	SNP	p	D95N	0	.	.	283	285	GAC	792	794	GAC	99;99;99	G;A,G,C,T;C	86;78,1,1,1;85	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1176	gyrA	2751	2751	99.78	gyrA.l6.c17.ctg.1	3695	95.1	1	SNP	p	D95G	0	.	.	283	285	GAC	792	794	GAC	99;99;99	G;A,G,C,T;C	86;78,1,1,1;85	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	531	520	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1883	82.5	0	.	p	.	0	P191fs	FSHIFT	571	571	C	1198	1198	C	151	C	124	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	531	520	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1883	82.5	1	SNP	p	G45D	0	.	.	133	135	GGC	759	761	GGC	149;148;148	G;G;C	127;124;125	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	340	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1364	74.4	0	.	n	.	0	.206T	INS	206	206	T	724	724	T	144	T	118	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1745	1747	GCC	119;118;118	G,C,T;C,T;C	100,1,1;101,1;95	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1787	1789	GCA	121;120;121	G;C,T;A,G	104;104,1;97,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	1	SNP	p	D86N	0	.	.	256	258	GAC	740	742	GAC	143;142;142	G;A,G,C;C	118;107,1,1;120	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	1	SNP	p	S87W	0	.	.	259	261	AGT	743	745	AGT	143;143;143	A;G;T	110;121;118	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	1	SNP	p	S87R	0	.	.	259	261	AGT	743	745	AGT	143;143;143	A;G;T	110;121;118	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	1	SNP	p	S87I	0	.	.	259	261	AGT	743	745	AGT	143;143;143	A;G;T	110;121;118	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1152	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3236	106.4	1	SNP	p	S88P	0	.	.	262	264	TCC	746	748	TCC	143;143;143	T;C;C	118;117;121	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	1022	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3109	98.5	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1689	1691	GGT	134;133;133	G;G,A;T,G	111;107,1;108,1	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1418	1420	GCA	141;141;143	G;C,A,G;A	117;119,1,1;120	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1421	1423	ATC	141;142;141	A;T;C	119;116;119	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1433	1435	GTG	141;141;140	G;T;G	121;116;118	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1433	1435	GTG	141;141;140	G;T;G	121;116;118	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1937	1939	ACC	115;117;116	A,G,C;C;C	93,1,1;95;97	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1991	1993	GCG	105;105;105	G;C;G,C	92;87;84,3	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1991	1993	GCG	105;105;105	G;C;G,C	92;87;84,3	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2114	2116	GGT	100;101;100	G,T;G;T	83,1;87;86	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2123	2125	GGC	102;102;102	G,C;G;C,T	84,1;88;87,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	890	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2712	98.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2141	2143	CCG	99;99;99	C,T;C;G	83,1;86;82	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1298	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3510	110.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1848	1850	CTG	111;111;113	C;T,C;G	87;85,1;89	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	624	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2083	89.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	535	537	GGC	115;116;116	G;G;C	93;92;95	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	624	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2083	89.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	717	717	C	100	C	84	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	583	585	ATG	165;165;165	A;T,G;G,A	131;132,1;135,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	673	675	GGA	154;155;155	G,T;G;A	125,1;122;124	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	V75I	NONSYN	223	225	GTT	754	756	ATT	150;149;147	A,C;T;T,C	123,2;126;123,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	T89S	NONSYN	265	267	ACC	796	798	AGC	144;144;145	A,C;G;C	122,1;125;129	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	V98I	NONSYN	292	294	GTC	823	825	ATC	131;131;134	A;T,G,A;C	115;115,1,1;125	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	.	MULTIPLE	358	359	AA	888	889	CG	136;135	C,A;G,A,C	119,1;115,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	.	MULTIPLE	361	362	GA	891	893	CAG	136;135;135	C,G,T;A;G,A	115,1,1;114;113,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	N122K	NONSYN	364	366	AAC	895	897	AAA	135;135;135	A;A;A,C	114;118;112,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	922	924	TAT	132;131;130	T,A;A,T;T	106,1;106,1;104	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	N134K	NONSYN	400	402	AAT	931	933	AAG	130;129;130	A;A;G,T	103;109;108,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	V135F	NONSYN	403	405	GTG	934	936	TTT	130;131;130	T,G,A;T,C;T,G	102,1,1;104,1;100,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	949	951	AAA	133;133;134	A,G,C;A,G;A	111,1,1;110,1;108	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	K143E	NONSYN	427	429	AAA	958	960	GAA	135;132;134	G,C;A;A	112,1;114;113	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	982	984	GCA	135;135;134	G;C,T;A	113;112,1;111	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1168	1170	TCA	134;134;134	T,A;C;A,C	111,1;109;108,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1288	1290	CAA	141;137;138	C;A;A	120;117;118	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	.	INDELS	760	762	ACA	1292	1296	ATCAA	139;138;137;137;137	A;T;C;A;A	116;118;117;118;115	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	.	INDELS	763	764	TG	1299	1301	AGT	138;139;140	A;G;T	117;114;115	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1306	1308	GAT	141;141;141	G,C;A;T	118,1;121;118	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1342	1344	AGC	146;147;149	A;G;C	125;125;126	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1414	1416	AGT	150;152;152	A;G;T	119;123;122	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1420	1422	GAC	148;148;148	G;A;C	119;117;119	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1423	1425	TAC	149;149;149	T;A;C	117;118;117	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	1	SNP	p	G120K	1	.	.	358	360	AAG	888	890	CGG	136;135;136	C,A;G,A,C;G,A	119,1;115,1,1;114,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	1	SNP	p	D121N	0	.	.	361	363	GAC	891	894	CGC	136;135;135	C,G,T;G,A;C	115,1,1;113,1;118	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	686	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1986	102.8	1	SNP	p	A121D	1	.	.	361	363	GAC	891	894	CGC	136;135;135	C,G,T;G,A;C	115,1,1;113,1;118	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2638	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5292	149.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2248	2250	CAT	131;133;133	C;A;T,G	109;110;112,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	362	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1345	80.4	1	SNP	p	V57M	1	.	.	169	171	ATG	713	715	ATG	159;159;160	A,C;T,C;G	121,1;121,1;122	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
